Sessions 2006-2014.

SOLACI organizes regional workshops since 2006 in various countries of Latin America.

In November 2006, the first edition of SOLACI Sessions in Guatemala City was conducted. Since then and a rate of 3 events  per year, SOLACI Sessions has organized meetings in different countries of South America, Central America, the Caribbean and the Andean and Pacific regions.

 

Next article

More articles by this author

Peru Sessions 2023

Held on November 16 and 17, 2023 in the Good Hope Clinic Auditorium, Lima, Peru! The XLVII SOLACI 2023 Regional Sessions (16th Andean Region) was...

Colombia Sessions 2022

XLV SOLACI Regional Sessions– 15° Andean Region. October 6, 7 & 8, 2022 The XLV SOLACI Regional Sessions (15th Andean Region) were held on October 6,...

Paraguay 2022 Sessions

44th SOLACI Regional Sessions - 15th Southern Cone Regional Meeting June 30th - July 1st The 44th SOLACI Regional Sessions (15th Region Southern Cone) took place...

Mexico Sessions 2021

The XLIV SOLACI Mexico Sessions 2021 were held on December 9, 2021 within the framework of the SOCIME 2021 Congress. The activity consisted of a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...